🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
Women undergoing myeloablative allogeneic hematopoietic cell transplant (MA...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2011-07
Trial ID
NCT01343368
Treatments Being Tested
This study investigates neoadjuvant TAK-700 orteronel for 6 months prior to...
Status
Terminated
Location
St Bartholomew's Hospital
Start Date
2013-02-18
Trial ID
NCT03211052
Treatments Being Tested
Aim to investigate the efficacy of follitropin alpha biosimilar therapy (Pr...
Status
Completed
Location
Center for reproductive medicine, Barnaul
Start Date
2020-01-12
Trial ID
NCT04854707
Hormone therapy, or androgen deprivation therapy (ADT) is a standard way to...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-31
Trial ID
NCT07783282
Treatments Being Tested
To determine the maximum-tolerated dose (MTD) of BKM120 when administered o...
Status
Terminated
Location
Institut Paoli Calmettes
Start Date
2014-10
Trial ID
NCT02487823
Treatments Being Tested
Men with progressive metastatic Castration-Resistant Prostate Cancer post f...
Status
Terminated
Location
Johns Hopkins Hospital
Start Date
2017-02-09
Trial ID
NCT02995330
Treatments Being Tested
Rationale: Laparoscopic myomectomy is increasingly performed over laparotom...
Status
Unknown
Location
Flevoziekenhuis
Start Date
2014-12
Trial ID
NCT02288130
Treatments Being Tested
This is a Phase III, global, randomized, open-label, multicenter, study eva...
Status
Active Not Recruiting
Location
Southern Cancer Center
Start Date
2021-08-27
Trial ID
NCT04961996
Treatments Being Tested
This phase II trial tests how well pembrolizumab along with standard of car...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-16
Trial ID
NCT06528210